Report Type: Therapy Reports
Report Category: Toxicology
Report Subcategory: Chemotherapy Induced Anemia
Price: $2999.00
Date: January 2022

Chemotherapy Induced Anemia: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Chemotherapy Induced Anemia
Chemotherapy-induced anemia (CIA) is a consequence of malignant invasion of normal tissue leading to blood loss, bone marrow infiltration with disruption of erythropoiesis, and functional iron deficiency as a consequence of inflammation.

Top 10 Companies:
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Pfizer Inc
Novartis AG
Sanofi
Amgen Inc
Teva Pharmaceutical Industries Ltd
Astellas Pharma Inc
Baxter International Inc
Kyowa Kirin Co Ltd